The Defense Logistics Agency (DLA) Troop Support Medical awarded an Indefinite Delivery Contract (IDC) worth up to $999,999,999 to Amerisourcebergen Drug Corp through December 2026. This single-award IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies from Amerisourcebergen to support military treatment programs and facilities worldwide. The contract covers the delivery of specialty medications, brand-name and generic drugs, vaccines, medical supplies, and equipment. Amerisourcebergen, a major pharmaceutical distributor, leverages its extensive supply chain network to provide critical care materials such as syringes, vials, and test kits, as well as a diverse range of medications across various therapeutic areas. This IDC serves as a primary vehicle for the DLA to obtain essential medical commodities, supporting the healthcare needs of military personnel, veterans, and other federal beneficiaries. The DLA has also awarded Amerisourcebergen a separate IDC worth up to $750,000 through May 2024 with the Department of Justice Federal Bureau of Investigation for similar pharmaceutical and medical products.
Generated 1/1/25, 9:05 AM